Insider trades
Pauwels Eric, Chief Officer of PTC Therapeutics PTCT, has filed 0 purchases and 60 sales on the open market. Over the past 12 months that comes to a net sale of $7.5M. The latest trade was on 06/10.
Pauwels Eric
Chief Business Officer
- Company
- PTC Therapeutics PTCT
- First filing
- 23/01/09
- Trades
- 101 trades
- Buys / sales
- 0 / 60
- 12-month net buying
- −$7.5M
- Last trade
- 06/10
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTCT | Open-market sale10b5-1 plan | 06/10 | 06/12 | 21,277 sh2 trades | $75.00avg. | $1,595,775 | −22.5% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 02/18 | 02/20 | 3,019 sh | $69.36 | $209,397.84 | −3.8% |
PTCT | Open-market sale10b5-1 plan | 01/08–01/12 | 01/12 | 7,348 sh5 trades | $77.02avg. | $565,946 | −8.4% |
PTCT | Open-market sale10b5-1 plan | 01/06–01/07 | 01/08 | 3,141 sh2 trades | $77.18avg. | $242,416.51 | −3.5% |
PTCT | Open-market sale10b5-1 plan | 25/12/19 | 25/12/23 | 20,508 sh10 trades | $77.26avg. | $1,584,349.85 | −22.6% |
PTCT | Open-market sale10b5-1 plan | 25/12/17–25/12/18 | 25/12/19 | 43,492 sh8 trades | $75.40avg. | $3,279,275.05 | −38.2% |
PTCT | Open-market sale10b5-1 plan | 25/09/08 | 25/09/09 | 39,850 sh7 trades | $56.92avg. | $2,268,374.13 | −35.3% |
PTCT | Open-market sale10b5-1 plan | 25/03/14–25/03/17 | 25/03/18 | 11,220 sh5 trades | $56.16avg. | $630,104.4 | −13.4% |
PTCT | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 2,945 sh2 trades | $50.11avg. | $147,575.84 | −3.4% |
PTCT | Open-market sale10b5-1 plan | 25/01/07–25/01/08 | 25/01/10 | 3,735 sh2 trades | $44.86avg. | $167,550.66 | −4.1% |
PTC TherapeuticsPTCT | Open-market sale | 24/04/17 | 24/04/19 | 787 sh | $25.14 | $19,785.18 | −1.1% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/01/30 | 24/02/01 | 366 sh | $27.25 | $9,973.5 | −0.8% |
PTCT | Open-market sale10b5-1 plan | 24/01/08–24/01/09 | 24/01/10 | 3,634 sh2 trades | $28.85avg. | $104,841.81 | −7.5% |
PTCT | Open-market sale10b5-1 plan | 23/05/19–23/05/22 | 23/05/23 | 8,416 sh3 trades | $58.97avg. | $496,315.62 | −15.0% |
PTCT | Open-market sale10b5-1 plan | 23/05/17–23/05/18 | 23/05/19 | 8,836 sh3 trades | $58.52avg. | $517,087.48 | −13.6% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 23/04/18 | 23/04/20 | 732 sh | $52.04 | $38,093.28 | −1.1% |
PTC TherapeuticsPTCT | Open-market sale | 23/01/31 | 23/02/02 | 375 sh | $45.63 | $17,111.25 | −0.6% |
PTC TherapeuticsPTCT | Open-market sale | 23/01/24 | 23/01/26 | 359 sh | $47.45 | $17,034.55 | −0.5% |
PTCT | Open-market sale | 23/01/10–23/01/11 | 23/01/12 | 1,234 sh2 trades | $43.59avg. | $53,792.15 | −1.8% |
PTC TherapeuticsPTCT | Open-market sale | 23/01/09 | 23/01/11 | 858 sh | $41.66 | $35,744.28 | −1.3% |